Review



dual-mode optical/magnetic resonance imaging (mri) nanoparticle probe  (Quantum Dot Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Quantum Dot Inc dual-mode optical/magnetic resonance imaging (mri) nanoparticle probe
    Dual Mode Optical/Magnetic Resonance Imaging (Mri) Nanoparticle Probe, supplied by Quantum Dot Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nanoparticles+for+optical+imaging/pm28013153-32-7-16?v=Quantum+Dot+Inc
    Average 90 stars, based on 1 article reviews
    dual-mode optical/magnetic resonance imaging (mri) nanoparticle probe - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    near-infrared fluorescence nanoparticles for targeted optical imaging  (Nanobiotix)
    90
    Nanobiotix near-infrared fluorescence nanoparticles for targeted optical imaging
    Technologies developed by CCNE awardees. The purpose of this table is to give the Reader an overview of the diversity of projects funded in CCNE grants. We were not able to include all projects – it would make the table too exhaustive. Each CCNE is represented with their most unique projects and also those which progressed to more advanced levels of maturity. The references in the table are not necessarily the most recent ones for a particular technology; they represent the status of work during the time the investigator was holding the grant. The last column in the table lists the company(ies) that licensed the technology for future commercialization and the clinical trial(s) number, if they are is being conducted for the technology.
    Near Infrared Fluorescence Nanoparticles For Targeted Optical Imaging, supplied by Nanobiotix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nanoparticles+for+optical+imaging/pmc06788937-180-36-34?v=Nanobiotix
    Average 90 stars, based on 1 article reviews
    near-infrared fluorescence nanoparticles for targeted optical imaging - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    dual-mode optical/magnetic resonance imaging (mri) nanoparticle probe  (Quantum Dot Inc)
    90
    Quantum Dot Inc dual-mode optical/magnetic resonance imaging (mri) nanoparticle probe
    Technologies developed by CCNE awardees. The purpose of this table is to give the Reader an overview of the diversity of projects funded in CCNE grants. We were not able to include all projects – it would make the table too exhaustive. Each CCNE is represented with their most unique projects and also those which progressed to more advanced levels of maturity. The references in the table are not necessarily the most recent ones for a particular technology; they represent the status of work during the time the investigator was holding the grant. The last column in the table lists the company(ies) that licensed the technology for future commercialization and the clinical trial(s) number, if they are is being conducted for the technology.
    Dual Mode Optical/Magnetic Resonance Imaging (Mri) Nanoparticle Probe, supplied by Quantum Dot Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nanoparticles+for+optical+imaging/pm28013153-32-7-16?v=Quantum+Dot+Inc
    Average 90 stars, based on 1 article reviews
    dual-mode optical/magnetic resonance imaging (mri) nanoparticle probe - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    tem images of 2-aminopyridyne-functionalized sphere sio2 nanoparticles at different optical magnifications philips cm-10  (Philips Healthcare)
    90
    Philips Healthcare tem images of 2-aminopyridyne-functionalized sphere sio2 nanoparticles at different optical magnifications philips cm-10
    Technologies developed by CCNE awardees. The purpose of this table is to give the Reader an overview of the diversity of projects funded in CCNE grants. We were not able to include all projects – it would make the table too exhaustive. Each CCNE is represented with their most unique projects and also those which progressed to more advanced levels of maturity. The references in the table are not necessarily the most recent ones for a particular technology; they represent the status of work during the time the investigator was holding the grant. The last column in the table lists the company(ies) that licensed the technology for future commercialization and the clinical trial(s) number, if they are is being conducted for the technology.
    Tem Images Of 2 Aminopyridyne Functionalized Sphere Sio2 Nanoparticles At Different Optical Magnifications Philips Cm 10, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nanoparticles+for+optical+imaging/10__1016_slash_j__cclet__2014__12__007-94-0-11?v=Philips+Healthcare
    Average 90 stars, based on 1 article reviews
    tem images of 2-aminopyridyne-functionalized sphere sio2 nanoparticles at different optical magnifications philips cm-10 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    nanoparticles for optical imaging  (Quantum Dot Inc)
    90
    Quantum Dot Inc nanoparticles for optical imaging
    Technologies developed by CCNE awardees. The purpose of this table is to give the Reader an overview of the diversity of projects funded in CCNE grants. We were not able to include all projects – it would make the table too exhaustive. Each CCNE is represented with their most unique projects and also those which progressed to more advanced levels of maturity. The references in the table are not necessarily the most recent ones for a particular technology; they represent the status of work during the time the investigator was holding the grant. The last column in the table lists the company(ies) that licensed the technology for future commercialization and the clinical trial(s) number, if they are is being conducted for the technology.
    Nanoparticles For Optical Imaging, supplied by Quantum Dot Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nanoparticles+for+optical+imaging/us07618937-232-112-96?v=Quantum+Dot+Inc
    Average 90 stars, based on 1 article reviews
    nanoparticles for optical imaging - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    nanoparticles for optical molecular imaging of atherosclerosis  (Verlag GmbH)
    90
    Verlag GmbH nanoparticles for optical molecular imaging of atherosclerosis
    Technologies developed by CCNE awardees. The purpose of this table is to give the Reader an overview of the diversity of projects funded in CCNE grants. We were not able to include all projects – it would make the table too exhaustive. Each CCNE is represented with their most unique projects and also those which progressed to more advanced levels of maturity. The references in the table are not necessarily the most recent ones for a particular technology; they represent the status of work during the time the investigator was holding the grant. The last column in the table lists the company(ies) that licensed the technology for future commercialization and the clinical trial(s) number, if they are is being conducted for the technology.
    Nanoparticles For Optical Molecular Imaging Of Atherosclerosis, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nanoparticles+for+optical+imaging/pm19226595-18-20-2?v=Verlag+GmbH
    Average 90 stars, based on 1 article reviews
    nanoparticles for optical molecular imaging of atherosclerosis - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Technologies developed by CCNE awardees. The purpose of this table is to give the Reader an overview of the diversity of projects funded in CCNE grants. We were not able to include all projects – it would make the table too exhaustive. Each CCNE is represented with their most unique projects and also those which progressed to more advanced levels of maturity. The references in the table are not necessarily the most recent ones for a particular technology; they represent the status of work during the time the investigator was holding the grant. The last column in the table lists the company(ies) that licensed the technology for future commercialization and the clinical trial(s) number, if they are is being conducted for the technology.

    Journal: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

    Article Title: NCI Alliance for Nanotechnology in Cancer – Catalysing Research and Translation Towards Novel Cancer Diagnostics and Therapeutics

    doi: 10.1002/wnan.1570

    Figure Lengend Snippet: Technologies developed by CCNE awardees. The purpose of this table is to give the Reader an overview of the diversity of projects funded in CCNE grants. We were not able to include all projects – it would make the table too exhaustive. Each CCNE is represented with their most unique projects and also those which progressed to more advanced levels of maturity. The references in the table are not necessarily the most recent ones for a particular technology; they represent the status of work during the time the investigator was holding the grant. The last column in the table lists the company(ies) that licensed the technology for future commercialization and the clinical trial(s) number, if they are is being conducted for the technology.

    Article Snippet: General Hospital ( Rai et al., 2010 ) Visudyne licensed to Bausch and Lomb Multifunctional nanoparticles in diagnosis and therapy of pancreatic cancer Paras Prasad SUNY-Buffalo ( Yong et al., 2009 ) Licensed to Nanobiotix Near-infrared fluorescence nanoparticles for targeted optical imaging Chun Li MD Anderson Cancer Center ( Zhang et al., 2011 ) Carestream Health DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment James Baker University of Michigan ( Myc et al., 2010 ) Avidimer Hybrid nanoparticles in imaging and therapy of prostate cancer Kattesh Katti University of Missouri ( Chanda et al., 2010 ) Nanoparticle Biochem Inc. Open in a separate window Technologies developed by R01 and U01 awardees.

    Techniques: Imaging, Diagnostic Assay, In Vitro, Luminex, DNA Methylation Assay, In Vivo

    Cumulative cancer clinical trials conducted for liposomal versus non-liposomal nanoparticles over time. This graph displays clinical trials performed for liposomal delivery systems (solid black bars – left axis) since the approval of Doxil in 1995. In comparison, all non-liposomal nanoparticle cancer clinical trials are displayed as solid blue fill, corresponding right axis. The information was derived from clinicaltrials.gov based on the following keyword searches ‘Cancer and – liposomal, Caelyx, Myocet, Lipodox, Onivyde, Depocyt, Daunoxome, Marquibo, Vyxeos, or Mepact’ and for non-liposomal ‘Cancer and nanoparticle or nanotechnology’. The nab-paclitaxel trials that were found were excluded from non-liposomal trials count. The year on the horizontal axis corresponds to the initiation of the trial.

    Journal: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

    Article Title: NCI Alliance for Nanotechnology in Cancer – Catalysing Research and Translation Towards Novel Cancer Diagnostics and Therapeutics

    doi: 10.1002/wnan.1570

    Figure Lengend Snippet: Cumulative cancer clinical trials conducted for liposomal versus non-liposomal nanoparticles over time. This graph displays clinical trials performed for liposomal delivery systems (solid black bars – left axis) since the approval of Doxil in 1995. In comparison, all non-liposomal nanoparticle cancer clinical trials are displayed as solid blue fill, corresponding right axis. The information was derived from clinicaltrials.gov based on the following keyword searches ‘Cancer and – liposomal, Caelyx, Myocet, Lipodox, Onivyde, Depocyt, Daunoxome, Marquibo, Vyxeos, or Mepact’ and for non-liposomal ‘Cancer and nanoparticle or nanotechnology’. The nab-paclitaxel trials that were found were excluded from non-liposomal trials count. The year on the horizontal axis corresponds to the initiation of the trial.

    Article Snippet: General Hospital ( Rai et al., 2010 ) Visudyne licensed to Bausch and Lomb Multifunctional nanoparticles in diagnosis and therapy of pancreatic cancer Paras Prasad SUNY-Buffalo ( Yong et al., 2009 ) Licensed to Nanobiotix Near-infrared fluorescence nanoparticles for targeted optical imaging Chun Li MD Anderson Cancer Center ( Zhang et al., 2011 ) Carestream Health DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment James Baker University of Michigan ( Myc et al., 2010 ) Avidimer Hybrid nanoparticles in imaging and therapy of prostate cancer Kattesh Katti University of Missouri ( Chanda et al., 2010 ) Nanoparticle Biochem Inc. Open in a separate window Technologies developed by R01 and U01 awardees.

    Techniques: Derivative Assay

    Table of clinical trials associated with technologies developed by Alliance investigators

    Journal: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

    Article Title: NCI Alliance for Nanotechnology in Cancer – Catalysing Research and Translation Towards Novel Cancer Diagnostics and Therapeutics

    doi: 10.1002/wnan.1570

    Figure Lengend Snippet: Table of clinical trials associated with technologies developed by Alliance investigators

    Article Snippet: General Hospital ( Rai et al., 2010 ) Visudyne licensed to Bausch and Lomb Multifunctional nanoparticles in diagnosis and therapy of pancreatic cancer Paras Prasad SUNY-Buffalo ( Yong et al., 2009 ) Licensed to Nanobiotix Near-infrared fluorescence nanoparticles for targeted optical imaging Chun Li MD Anderson Cancer Center ( Zhang et al., 2011 ) Carestream Health DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment James Baker University of Michigan ( Myc et al., 2010 ) Avidimer Hybrid nanoparticles in imaging and therapy of prostate cancer Kattesh Katti University of Missouri ( Chanda et al., 2010 ) Nanoparticle Biochem Inc. Open in a separate window Technologies developed by R01 and U01 awardees.

    Techniques: Modification, Diagnostic Assay, Imaging, Small Interfering RNA